Cargando…
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt
BACKGROUND: Multi- criteria decision analysis (MCDA) can assist policymakers in objectively choosing between alternative therapeutic options based on multiple value attributes. Our aim was to create an MCDA tool for the national tenders of off-patent oncology medicines in Egypt. METHODS: An initial...
Autores principales: | Elezbawy, Baher, Fasseeh, Ahmad Nader, Sedrak, Amal, Eldessouki, Randa, Gamal, Mary, Eldebeiky, Mariam, Amer, Hanaa, Akeel, Shimaa, Morsy, Ahmad, Amin, Amira, Shafik, Amr, Abaza, Sherif, Kaló, Zoltán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886839/ https://www.ncbi.nlm.nih.gov/pubmed/35232487 http://dx.doi.org/10.1186/s40545-022-00414-2 |
Ejemplares similares
-
A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt
por: Elezbawy, Baher, et al.
Publicado: (2022) -
Maximizing the benefits of using biosimilars in Egypt
por: Fasseeh, Ahmad Nader, et al.
Publicado: (2023) -
Healthcare financing in Egypt: a systematic literature review.
por: Fasseeh, Ahmad, et al.
Publicado: (2022) -
Recommendation for a Pilot MCDA Tool to Support the Value-Based Purchasing of Generic Medicines in the UAE
por: Farghaly, Mohamed Naser, et al.
Publicado: (2021) -
A roadmap toward implementing health technology assessment in Egypt
por: Fasseeh, Ahmad Nader, et al.
Publicado: (2022)